“It’s the only thing that’s going to help me sleep.”
That’s how Dr. Mark Nisbet, an associate professor of psychiatry at Columbia University, describes the technology that is supposed to help him do just that.
The device is called the BreatheIn.
It’s an electric-pressure mask that contains air bubbles to simulate breathing.
And when you breathe into it, it inflates, so that the mask will create a very deep and full inhalation.
Nisbit says the device was designed to make breathing more like a physical exercise, rather than a mental one.
“We’re going to do a physical task and then we’re going be able to control the intensity and the duration and the amount of stimulation,” he says.
“There’s no mental component.”
Breathein’s makers, AstraZeneca and GSK, are still figuring out the technology’s exact role in the treatment of respiratory distress, but they’ve made strides in getting people comfortable with it.
And they’re still figuring it out.
“It doesn’t just work,” Nisbitsays.
“I can actually actually feel the air flow through my lungs.
It actually feels like you’re breathing.”
It’s a long road.
Nissiesvech, who works in an emergency department in Chicago, has tried breathing using the Breathes in device for years, and he’s a proponent.
“When I have an asthma attack or something like that, it’s hard for me to breathe and feel good,” he told ABC News.
“And you don’t want to go through an attack again.”
He’s been taking Breathe In for several years, but he still has trouble sleeping.
“If I’m doing a physical activity like yoga or swimming or whatever, I’m going to get used to it,” he said.
“But when I go to sleep I can’t sleep at all.”
Breathing device’s maker, Astrahal, is also testing the device, but its researchers say it’s still not perfect.
The company says it’s been testing the BreathIn on people in Germany, but it hasn’t yet tested it in the U.S. or in Australia.
The U.K. government has approved Breathe in, but there are no plans to roll it out in Britain.
And despite being marketed as a breathing device, the company says its inhalation mode is not meant to be inhaled.
The technology also has problems when it comes to its safety.
The devices have a tendency to leak, which can lead to a potentially life-threatening reaction in people who have breathing problems.
The BreatheIN is also not designed to be worn on the face or in a way that could trigger allergic reactions.
The inhalation device’s manufacturer says it could help with the breathing problems that are a problem in about 10% of people with asthma.
But Nisbett, the Harvard professor, says the technology is a “tough sell” for people who are suffering from asthma.
“To be honest, it doesn’t help,” Nissysvech says.
Breathe into the Breathing In device, Nisbs is able to exhale deeply and deeply, but the pressure inside the device does not increase enough to create a full inhalational burst.
That means Nisbbys breath becomes “deep and shallow,” which makes breathing difficult.
“So if you are not breathing deeply enough to do that, you end up with an uncomfortable and painful airway,” Nisesvot says.
Nisesvsvech is worried about the technology getting into the hands of terrorists and criminals.
“The people that have this technology in their hands and are using it, they’re going have a lot of problems,” he explains.
“That is, it will be used against people who might be in an extremist or terrorist group.
So, you know, we’re talking about people who maybe have an ideology, or are in a group that may have an extremist ideology.”
But he says it may also be useful for people suffering from chronic coughs, as it can help mask their symptoms.
“People with chronic cough can really suffer from the coughs and wheezes and the gas, and they really want to mask it, so they’ll have a really bad cough,” NISbitsch says, adding that people who suffer from asthma will have a harder time masking their symptoms, too.
“You can actually feel that air flow in the lungs and so it’s much better for them than when they don’t have it,” Nislawsvech explains.
Breathing machines like Breatheins are just one part of the larger debate over how best to combat respiratory distress.
A 2015 study by the National Institute of Allergy and Infectious Diseases found that in 2016, the number of Americans diagnosed with COPD doubled from 1.7 million to 3.6 million.
While the research shows that respiratory distress is a major health issue in the United States, the research is far from conclusive.
Many studies have found that COP